| Address: | Level 4, LIMS 2 LaTrobe University, Bundoora VIC 3083, Australia |
|---|---|
| Postal code: | 3083 |
| Phone: | (03) 9479 1210 |
| Website: | http://www.hexima.com.au/ |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Hexima Limited, use the form below and your opinion, advice or comment will appear in this space.
Hexima Limited is a biotechnology company actively engaged in the research and development of plant-derived molecules for use in human health and agriculture. About. About Us. ... Phone: +61 3 9479 1210. Stay up to date. For the latest shareholder information & investor news, subscribe to our email alerts. ...
See the company profile for Hexima Limited (HXL.AX) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ...
Find the latest Hexima Limited (HXL.AX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Hexima Limited (03) 9479 1210. Lvl 4/ LIMS 2/, La Trobe University VIC 3086 Save Contact. Share via SMS Share via SMS. Hexima Limited Lvl 4/ LIMS 2/, La Trobe University VIC 3086. Phone: (03) 9479 1210 SMS these details to your mobile phone for free: Send We won't use your number for marketing purposes. ...
Hexima Limited (ASX:HXL) | 481 followers on LinkedIn. Clinical stage, anti-infectives biotech company developing defensin peptides for applications as human therapeutics. | Hexima is a clinical ...
HEXIMA LIMITED. Hexima Limited is an Australia-based clinical stage, anti-infectives focused biotechnology company, which is engaged in the research and development of defensin peptides for applications as human therapeutics. The Company’s lead product candidate, pezadeftide applied in a topical formulation, is a new prescription ...
Hexima Limited Information. Hexima is a clinical-stage biotechnology company developing plant-derived proteins and peptides as human antifungal therapeutics. Its lead drug candidate, HXP124, is in phase I/IIa clinical trials for the treatment of fungal toenail infections (onychomycosis). HXP124 is a member of the Plant Defensin family of ...
Contact and general information about Hexima Limited company, headquarter location in Melbourne, Victoria. Email formats & phone numbers of Hexima Limited 10-50 employees. Biotechnology
Get Hexima Limited HXL.AX price, chart, market capitalization and other stock info about Hexima Limited. Open this page to get detailed information about HXL.AX traded on ASX exchange in Australia. en ... 61 3 9479 1210: Website: https://www.hexima.com.au: Industry: Biotechnology: Sector(s)